Home » Canadian Gov't Grants Med BioGene $262K to Develop CVD Biomarkers

Canadian Gov't Grants Med BioGene $262K to Develop CVD Biomarkers

Feb 12, 2007
NEW YORK (GenomeWeb News) — Diagnostics developer Med BioGene has received a CA$307,000 ($262,000) grant from the Canadian government to develop biomarkers to help physicians detect and manage cardiovascular disease, the company said Friday.
 
The grant came from the National Research Council Canada Industrial Assistance Program.
 
MBI, based in Vancouver, BC, said it is working with CVD patient samples provided by the University of Ottawa Heart Institute to confirm its biomarkers.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

Threats of Synthetic Biology

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Deletion Is Hard to Do

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

So Just How Many Are There?

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

This Week in Genome Research

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.

What's Popular?

In Microarrays & Multiplexing

  1. MS Risk Linked to HLA Haplotype Mediated by Altered Methylation

  2. Bipolar, Schizophrenia GWAS Leads to Shared, Distinct Risk Variants

  3. Mt. Sinai-Led Team Develops RNA Sequencing Classifier to Diagnose Mild, Moderate Asthma

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.